Sign In for increased benefits
Turn your one-off questions into a powerhouse research hub.
๐จ
Real-time alerts on your custom watchlists
๐
Unlock Deep Research Mode
๐
Exportable PDF/Word reports
๐
Revisit every question in your account history
โญ
Get personalised research and news based on your past questions
๐ค
Team collaborate & annotate insights
๐
Sync across devicesโnever lose your place
๐
Early-access to the next big AI features
๐
Continue enjoying 40 questions daily on your free account
Maybe Later
Sign In Now
About Us
FAQs
Contact Us
Privacy Policy
Cookies Policy
Terms and Condition
Acceptable Use Policy
Data Processing Addendum
๐ข
New Earnings
In
!
๐
Dafinchi
Sign In
Latest Earnings
Earnings Chat
Earnings Feed
Companies
Earnings Feed
Hide Filters
Varonis Systems, Inc.
VRNS
2025 Q2
Technology
2w
Financial Performance Summary
ARR contribution margin improved to 16.5% from 14.9% last year.
Cash and equivalents totaled $1.2 billion as of June 30, 2025.
Gross profit was $122.6 million with a gross margin of 80.6%, down from 84.1% in Q2 2024.
Net income was $3.8 million or $0.03 per diluted share versus $6.8 million or $0.05 per diluted share last year.
Operating loss was $1.9 million or -1.2% operating margin compared to operating income of $2.1 million last year.
Q2 ARR grew 19% year-over-year to $693.2 million with SaaS ARR representing about 69% of total ARR.
Share repurchases totaled 2.5 million shares for $100 million year-to-date.
Total revenues for Q2 were $152.2 million, up 17% year-over-year, with SaaS revenues at $105.9 million.
Year-to-date free cash flow was $82.7 million, up from $67.3 million last year.
Explore Similar Insights
Genpact Limited
G
2025 Q2
Technology
1w
Financial Performance Summary
Adjusted diluted EPS grew 11.4% year-over-year to $0.88, exceeding the high end of guidance.
Genpact reported Q2 2025 revenue of $1.25 billion, up 7% year-over-year, driven by broad-based business growth.
Gross margin expanded by 50 basis points to 35.9%, and adjusted operating income margin increased by 40 basis points to 17.3%.
Non-FTE revenue accounted for 46% of total revenue, consistent with the prior year.
Operating cash flow was $177 million, down from $209 million in the prior year, with cash and equivalents at $663 million.